ACR Convergence 2025| Video: Rheuminations on Milestones & Ageism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: liver

anaken2012/shutterstock.com

Legalities of Telemedicine

Kathy Holliman, MEd  |  October 15, 2015

A brief has been filed with the U.S. Supreme Court that, if the court decides to hear the case, could have wide-ranging implications for online medical care and the limits of a physician’s First Amendment right to free speech. Medical Advice Via e-Mail Institute for Justice Senior Attorney Jeff Rowes filed the brief at the…

Filed under:Legal UpdatesPractice SupportProfessional TopicsTechnology Tagged with:ConsultationLegalpatient carePractice ManagementrheumatologyTechnologytelemedicine

Opinion: Insurance Companies Use Medically and Fiscally Irresponsible Formularies

Bruce Rothschild, MD  |  October 14, 2015

Receipt of an unsolicited communication that a sweepstakes award has been won may con some people (especially, but not limited to, those underprivileged or undereducated as to legalities), but can’t fool all of the people all of the time. The names of the organizations and products involved are often marketing tool inventions, which imply special…

Filed under:EthicsInsuranceLegal UpdatesProfessional Topics Tagged with:formulariesinsuranceLegalrheumatology

Dr. Yokoyama, MD, with Jennifer Laurent

Interdisciplinary Collaboration at Wash U Advances Understanding of Immunology, Rheumatology

Gretchen Henkel  |  October 14, 2015

In June 2014, 10 members of a church group returned to St. Louis from Haiti, where they had contracted chikungunya virus (CHIKV), a mosquito-transmitted alphavirus previously unknown in the Western hemisphere that produces inflammatory arthritis symptoms. Because CHIKV-related arthritis mimics seronegative RA, a group of clinicians, immunologists, virologists and geneticists at the Washington University in…

Filed under:ConditionsOther Rheumatic ConditionsProfessional TopicsResearch Rheum Tagged with:CHIKVclinical trialscontracted chikungunya virusImmunologyoutcomeResearchrheumatology

FDA Issues Stronger Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Warning

Michele B. Kaufman, PharmD, CGP, RPh  |  October 14, 2015

The U.S. Food and Drug Administration (FDA) has toughened the existing warnings for nonsteroidal anti-inflammatory drugs (NSAIDs) due to their stroke and myocardial infarction (MI) risk increase.1 Due to a continual review of these products, FDA is requiring label updates for all prescription NSAIDs. Over-the-counter (OTC) NSAIDs already list the increased risk of MI and…

Filed under:ConditionsDrug UpdatesOther Rheumatic ConditionsResearch Rheum Tagged with:abaloparatideadverse eventsanti-inflammatoryclinical trialsdrugFDAMIMyocardial infarctionnonsteroidal anti-inflammatory drugsNSAIDsoutcomeResearchrheumatologyriskSafetystroketofacitinib citrate

Rheumatologists Share Research, Successes at Annual Investigators’ Meeting

From the College  |  October 14, 2015

“Each project adds new knowledge that brings us a little closer to the cure,” Joan Bathon, MD, of Columbia University Medical Center, says of the Rheumatology Research Foundation’s 8th Annual Investigators’ Meeting in San Diego. Dr. Bathon was one of more than 30 investigators who presented the latest progress on research funded by the Foundation’s…

Filed under:Career DevelopmentConditionsEducation & TrainingFrom the CollegeMeeting ReportsProfessional TopicsResearch RheumRheumatoid Arthritis Tagged with:education and trainingRAResearchRheumatoid arthritisrheumatologistsrheumatology

FOCIS 2015: Key Protein Found to Control Trafficking of Toll-like Receptors

Catherine Kolonko  |  October 13, 2015

Gregory Barton, PhD, professor of immunology and pathogenesis, University of California, Berkeley, talked about research on the innate immune system and a key protein involved in the trafficking of a subset of toll-like receptors (TLRs) during FOCIS 2015 in San Diego. To keep the body healthy, the immune system responds constantly to foreign cellular invaders…

Filed under:ConditionsMeeting ReportsResearch Rheum Tagged with:ClinicalDiseaseinnate immune systemproteinResearchTLRsToll-like receptors

ARHP Celebrates Milestones on 50th Anniversary

Erin Latimer Meadows  |  October 13, 2015

How do you tell a story 50 years in the making? How do you capture 50 years of achievements, moments, personal and professional relationships, and careers shaped? How do you define the exact moment collaborative and integrated care teams became the rule—not the exception—in rheumatology? To journey through the milestones that have led to the…

Filed under:Career DevelopmentProfessional Topics Tagged with:Association of Rheumatology Professionals (ARP)EducationLeadershipProfessional MattersrheumatologyTraining

Rawpixel/shutterstock.com

Racial Disparities Result in Unprecedented Differences in Outcomes for SLE Patients

Eric L. Wise, MD, & W. Joseph McCune, MD  |  October 13, 2015

The differences between Caucasian and minority patients with lupus are striking: In almost all aspects of the disease, black, Hispanic and many Asian lupus patients do poorly compared with their white counterparts. Although racial disparities in outcomes in the practice of medicine are widespread, the scope and degree of the differences in lupus is, with…

Filed under:ConditionsSystemic Lupus Erythematosus Tagged with:ClinicalLupusOutcomesracial disparitiesSLESystemic lupus erythematosus

Case Report: Interstitial Lung Disease with Positive ANCA Test

Sara Tedeschi, MD  |  October 13, 2015

“Worst of all is the pain in my calves,” she said. “It feels like burning deep inside.” So began my first encounter with a 69-year-old woman who was referred to rheumatology clinic for evaluation of two months of constitutional symptoms and a positive ANCA test, which had been ordered by her primary care doctor. Her…

Filed under:Conditions Tagged with:ANCA patient careClinicalDiagnosisILDInterstitial Lung Diseaseoutcome

Transatlantic Divide: How U.S. Pays Three Times More for Drugs

Reuters  |  October 13, 2015

LONDON (Reuters)—U.S. prices for the world’s 20 top-selling medicines are, on average, three times higher than in Britain, according to an analysis carried out for Reuters. The finding underscores a transatlantic gulf between the price of treatments for a range of diseases and follows demands for lower drug costs in America from industry critics such…

Filed under:Drug Updates Tagged with:costsdrugpharmaceutical company

  • « Previous Page
  • 1
  • …
  • 85
  • 86
  • 87
  • 88
  • 89
  • …
  • 128
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences